Yes, indeed! Nurosym is at the forefront of scientific research, continuously investing substantial resources to advance neuromodulation technology. With over $10 million dedicated to studies, we collaborate with over 60 esteemed organizations, including Harvard and UCL, to deepen understanding and improve outcomes.
Our research has resulted in 50+ peer-reviewed papers in leading journals such as Nature and Nature Reviews Cardiology. This includes a meta-analysis of placebo-controlled cardiac studies in JACC, a highly reputable journal with a 21.7 impact factor, ranking among the world’s top 100 journals. These studies highlight exciting breakthroughs in modulating Vagus Nerve Activity, Heart Rate Variability, and more.
We’ve made study findings accessible on our Scientific Evidence page, summarizing key insights for ease of understanding. While many journals use paywalls or technical language, our scientific team has synthesized the information for broader accessibility. Healthcare professionals can also apply for curated access to all our papers through this link.
Benefits of Nurosym Research
Extensive studies have uncovered remarkable benefits, including:
- 61% increase in Vagus Nerve Activity in 5 minutes
- 18% increase in Heart Rate Variability
- 13% improvement in sleep
- 48% improvement in fatigue
- 40% improvement in post-viral fatigue symptoms (e.g., brain fog, pain, GI symptoms)
- 78% reduction in inflammation
- 32% improvement in memory and 29% in reading
These results showcase why Nurosym is widely regarded as the gold standard in neuromodulation.
Disclaimer
Results are based on specific study populations, and individual outcomes may vary. This information is not intended as medical advice. Please consult a qualified healthcare provider for personalized guidance.